Search Results - "Pfister, Thomas D."
-
1
ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses
Published in Cancer research (Chicago, Ill.) (01-12-2014)“…Camptothecin and its derivatives, topotecan and irinotecan, are specific topoisomerase I (Top1) inhibitors and potent anticancer drugs killing cancer cells by…”
Get full text
Journal Article -
2
Enhancing Mn(II)-Binding and Manganese Peroxidase Activity in a Designed Cytochrome c Peroxidase through Fine-Tuning Secondary-Sphere Interactions
Published in Biochemistry (Easton) (15-03-2016)“…Noncovalent second-shell interactions are important in controlling metal-binding affinity and activity in metalloenzymes, but fine-tuning these interactions in…”
Get full text
Journal Article -
3
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
Published in Molecular cancer therapeutics (01-07-2009)“…Topoisomerase I (Top1) is a proven target for cancer therapeutics, and the level of Top1 in tumors has been used as a biomarker for chemotherapeutic efficacy…”
Get full text
Journal Article -
4
Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells
Published in PloS one (21-06-2018)“…The presence of cancer stem cells (CSCs) and the induction of epithelial-to-mesenchymal transition (EMT) in tumors are associated with tumor aggressiveness,…”
Get full text
Journal Article -
5
Identifying the Elusive Sites of Tyrosyl Radicals in Cytochrome c Peroxidase: Implications for Oxidation of Substrates Bound at a Site Remote from the Heme
Published in Biochemistry (Easton) (17-06-2014)“…The location of the Trp radical and the catalytic function of the [Fe(IV)O Trp191 •+] intermediate in cytochrome c peroxidase (CcP) are well-established;…”
Get full text
Journal Article -
6
A Site-Selective Dual Anchoring Strategy for Artificial Metalloprotein Design
Published in Journal of the American Chemical Society (08-09-2004)“…Introducing nonnative metal ions or metal-containing prosthetic groups into a protein can dramatically expand the repertoire of its functionalities and thus…”
Get full text
Journal Article -
7
The Root Causes of Pharmacodynamic Assay Failure
Published in Seminars in oncology (01-08-2016)“…Robust pharmacodynamic assay results are valuable for informing go/no‐go decisions about continued development of new anti-cancer agents and for identifying…”
Get full text
Journal Article -
8
Neutral Thiol as a Proximal Ligand to Ferrous Heme Iron: Implications for Heme Proteins That Lose Cysteine Thiolate Ligation on Reduction
Published in Proceedings of the National Academy of Sciences - PNAS (01-04-2003)“…Cysteine plays a key role as a metal ligand in metalloproteins. In all well-recognized cases, however, it is the anionic cysteinate that coordinates. Several…”
Get full text
Journal Article -
9
Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues
Published in PloS one (28-12-2012)“…Topoisomerase I (Top1) is a proven target for cancer therapeutics. Recent data from the Fluorouracil, Oxaliplatin, CPT-11: Use and Sequencing (FOCUS) trial…”
Get full text
Journal Article -
10
Safety, immunologic and clinical activity of Durvalumab in combination with Olaparib or Cediranib in advanced leiomyosarcoma: Results of the DAPPER clinical trial
Published in Clinical cancer research (13-10-2023)“…Non-inflamed (cold) tumors such as leiomyosarcoma (LMS) do not benefit from immune checkpoint blockade (ICB) monotherapy. Combining ICB with angiogenesis-, or…”
Get full text
Journal Article -
11
119 Uncovering spatial biology of mouse tumor immune microenvironment using imaging mass cytometry
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundAdvances in therapies targeting immuno-oncological processes that dictate tumor growth, metastasis, and immune response require comprehensive…”
Get full text
Journal Article -
12
Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays
Published in Clinical cancer research (15-07-2016)“…Rational development of targeted MET inhibitors for cancer treatment requires a quantitative understanding of target pharmacodynamics, including molecular…”
Get full text
Journal Article -
13
Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells
Published in Clinical cancer research (01-02-2010)“…Purpose: Circulating tumor cells (CTC) in peripheral blood of patients potentially represent a fraction of solid tumor cells available for more frequent…”
Get full text
Journal Article -
14
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
Published in Cancer chemotherapy and pharmacology (01-07-2016)“…Purpose Indenoisoquinolines are non-camptothecin topoisomerase I (TopI) inhibitors that overcome the limitations of camptothecins: chemical instability and…”
Get full text
Journal Article -
15
Engineering Novel Metalloproteins: Design of Metal-Binding Sites into Native Protein Scaffolds
Published in Chemical reviews (01-10-2001)“…The protein design process can be divided into two steps: the design of overall scaffold and the design of active sites. Lu et al focus on the creation of…”
Get full text
Journal Article -
16
Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron
Published in Cancer research (Chicago, Ill.) (15-03-2010)“…Because topoisomerase 1 (TOP1) is critical for the relaxation of DNA supercoils and because it is the target for the anticancer activity of camptothecins, we…”
Get full text
Journal Article -
17
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations
Published in Journal of experimental & clinical cancer research (31-03-2016)“…DNA topoisomerase I (Top1) is a DNA unwinding protein and the specific target of the camptothecin class of chemotherapeutic drugs. One of these, irinotecan,…”
Get full text
Journal Article -
18
Abstract 5544: Development of recombinant transcription factor proteins and antibodies for application in clinical immunoassays
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract EMT/stem cell transcription factors have been implicated in the differentiation of epithelial cells into mesenchymal cells (epithelial-mesenchymal…”
Get full text
Journal Article -
19
Monooxygenation of an aromatic ring by F43W/H64D/V68I myoglobin mutant and hydrogen peroxide. Myoglobin mutants as a model for P450 hydroxylation chemistry
Published in The Journal of biological chemistry (01-04-2005)“…Myoglobin (Mb) is used as a model system for other heme proteins and the reactions they catalyze. The latest novel function to be proposed for myoglobin is a…”
Get full text
Journal Article -
20
Insect freeze tolerance: Roles of protein phosphatases and protein kinase A
Published in Insect biochemistry and molecular biology (2006)“…Freeze-tolerant larvae of the goldenrod gall fly, Eurosta solidaginis Fitch, show multiple metabolic adaptations for subzero survival including the autumn…”
Get full text
Journal Article